Sam Brusco, Associate Editor06.02.21
Baxter launched the Sharesource Analytics 1.0 premium module, a next-generation digital health device for home-based peritoneal dialysis (PD). Sharesource Analytics 1.0 is a clinical management resource within the Sharesource remote patient management platform that provides a comprehensive dashboard containing simplified trend data from home dialysis treatments. Baxter plans to launch Sharesource Analytics 1.0 globally, initiating in the United States, on a rolling basis over the next year and making it available by subscription.
Sharesource Analytics 1.0 delivers intuitive and clinically meaningful data that may be used to identify potentially slow-building issues over the patient’s last 180 days of therapy. This data provides clarity to healthcare professionals around their patients’ adherence, catheter function and therapy fatigue—three issues often associated with therapy dropout.1 It also provides healthcare professionals with evidence-based clinical guidance to aid in making informed decisions to resolve the potential complications their home patients may be experiencing.
“Sharesource remote patient management platform has played a significant role through the COVID-19 pandemic in allowing patients with kidney failure—who often have immune dysfunction—to do their dialysis at home, where they can remain safer by socially distancing,” Peter Rutherford, M.D., senior medical director, Baxter Renal Care business told the press. “With the launch of Sharesource Analytics 1.0, Baxter is again pioneering the next generation of digital health for nephrology that is designed to further empower remote clinical management of home dialysis patients.”
Reference
1 Mujais S, Story K. Peritoneal dialysis in the US: evaluation of outcomes in contemporary cohorts. Kidney Int Suppl. 2006 Nov;(103):S21-6.
Sharesource Analytics 1.0 delivers intuitive and clinically meaningful data that may be used to identify potentially slow-building issues over the patient’s last 180 days of therapy. This data provides clarity to healthcare professionals around their patients’ adherence, catheter function and therapy fatigue—three issues often associated with therapy dropout.1 It also provides healthcare professionals with evidence-based clinical guidance to aid in making informed decisions to resolve the potential complications their home patients may be experiencing.
“Sharesource remote patient management platform has played a significant role through the COVID-19 pandemic in allowing patients with kidney failure—who often have immune dysfunction—to do their dialysis at home, where they can remain safer by socially distancing,” Peter Rutherford, M.D., senior medical director, Baxter Renal Care business told the press. “With the launch of Sharesource Analytics 1.0, Baxter is again pioneering the next generation of digital health for nephrology that is designed to further empower remote clinical management of home dialysis patients.”
Reference
1 Mujais S, Story K. Peritoneal dialysis in the US: evaluation of outcomes in contemporary cohorts. Kidney Int Suppl. 2006 Nov;(103):S21-6.
